// STATE LEGISLATION TRACKER

Massachusetts S3064 — An Act to build resilience for Massachusetts communities

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Massachusetts
Bill: S3064
Filed: 2026-04-15
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Based only on the title and limited metadata, this appears to be a broad community resilience bill, not a peptide, prescribing, telehealth, compounding, or clinician-scope bill. No peptide-ecosystem impact can be identified from the available information.

Key Points

No direct peptide access issue is visible from the title or metadata
No apparent change to compounded peptides or FDA 503A/503B rules
No visible impact on off-label prescribing, telehealth, NP, or naturopath scope
No controlled-substance or prescription-monitoring signal is available

What to Watch For

Note Full bill text or subject tags should be checked if they become available.

Note Watch for amendments that mention prescribing, pharmacies, telehealth, or clinician scope.

Where the Bill Stands

The latest action is unavailable, so the bill's current position in the Massachusetts process cannot be confirmed from the provided metadata.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws